SEC61A1 and nasopharyngeal carcinoma: Additionally, Cao et al. showed the involvement of the MAGI2-AS3/miR-218-5p/GDPD5/SEC61A1 axis in cisplatin resistance in nasopharyngeal carcinoma [74].